1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jan 12, 2022
Most Recent Trade
2
Credibility
Score
Score
25%
Hit Rate
-23.7%
Avg 90d Return
-23.9%
Median 90d Return
4
Evaluated Trades
+0.9%
Best Trade
-47.7%
Worst Trade
Hit rate and returns are based on 4 open-market buys with evaluable
90-day outcomes. Score reflects historical conviction, not a guarantee of future performance.
Limited signal — either below-average timing or insufficient trade history.
| Date | Company | Dir. | Value |
|---|---|---|---|
| Jan 12, 2022 |
$XRTX
XORTX Therapeutics Inc.
|
Buy | — |
| Dec 02, 2021 |
$XRTX
XORTX Therapeutics Inc.
|
Buy | $8K |
| Nov 09, 2021 |
$XRTX
XORTX Therapeutics Inc.
|
Buy | $10K |
| Oct 27, 2021 |
$XRTX
XORTX Therapeutics Inc.
|
Buy | $10K |
| Sep 24, 2021 |
$XRTX
XORTX Therapeutics Inc.
|
Sell | — |
Muted rows are plan purchases, compensation grants, or DRIP — not open-market.
Signal scores reflect the company's current score, not the score at time of trade.